Puro Risk Insights Blog
Our blog is an educational hub for clear and timely insights on the cannabis and hemp industry.
We simplify insurance topics regulatory updates and real world risks into easy to understand content for operators at every stage.
From cultivation to retail we provide practical guidance coverage education and market insights to help you stay compliant protected and informed so you can make smarter and more confident decisions.
ON THE BLOG
CATEGORIES
FEATURED POST
Recent Industry Updates
All Articles
Browse our complete collection of cannabis and hemp insights below. This page brings together all published articles covering policy and regulation, business and economy, legal and justice, industry innovation, and culture and community. Each post is created to educate and inform operators and industry stakeholders by breaking down complex topics into clear, practical insights. Scroll down to explore the full library and stay informed on the issues shaping the industry.
Veterans, Cannabis, and a New Chapter: VFW Partners with Torch to Launch THC-Infused Drinks
The VFW is partnering with Torch Beverage Company to sell hemp-derived THC seltzers across 27 states—marking a cultural shift in how cannabis is viewed by veterans and the mainstream. Proceeds will go toward supporting veterans in need, bridging wellness and advocacy through responsible cannabis use.
Kentucky Approves Its Second Medical Cannabis Cultivator: A Sign of What’s Coming
Kentucky just approved its second medical cannabis cultivator, signaling major progress for the state’s new program. This marks a turning point for southern cannabis markets—and a growing opportunity for early operators ready to enter responsibly.
When Equity Fails: Lessons from San Francisco’s First Cannabis Equity Store
San Francisco’s first cannabis equity dispensary was meant to symbolize fairness but instead ended in failure. Reports of City Hall insiders profiting highlight how equity programs can fall short, raising hard lessons for operators and investors alike.
FDA Begins Tracking Adverse Events for Hemp and CBD Products
The FDA has begun actively tracking adverse health events linked to hemp and CBD products. This new reporting process marks a step toward greater federal oversight and signals important changes ahead for operators, investors, and consumers.
When Politics Moves Markets: How One Comment Sparked a Cannabis Rally
Cannabis stocks rallied sharply after Donald Trump suggested Medicare could cover CBD in senior healthcare. While no policy has changed, the surge proves how political commentary still drives cannabis markets. Here’s what operators and investors can learn from this moment.
Breaking Into New York’s Cannabis Market: Lessons from Silly Nice
Breaking into New York’s cannabis market is no easy task. Silly Nice shows how quality, transparency, and bold branding can help cannabis businesses stand out and succeed in a crowded space.
Illegal Grows Are Being Shut Down — Is Your Cannabis Business Protected?
Illegal cannabis grows are being shut down across California, highlighting the risks of non-compliance. Learn how licensed operators can protect their business with the right safeguards and insurance coverage.
Cannabis Compliance Challenges in 2025: How to Stay Ahead
Cannabis compliance is tightening as federal reform nears. From testing issues to OSHA and cGMP standards, businesses must adopt proactive strategies to stay competitive.
Disclaimer: All content on this site is for informational and educational purposes only. We share news, insights, and our own interpretations but do not claim ownership of third-party content, always crediting original sources with links. Views expressed in shared content do not necessarily reflect our own. For accurate and current information, please consult the original publisher.
Ready to review your cannabis coverage?
Call us on (323)905-3396
or growth@cannashield.io

Minnesota surpassed $250 million in cannabis sales during its first full year of statewide licensed retail, while cultivation capacity and social equity participation expanded rapidly. The next test is whether rising supply can improve product availability without putting unsustainable pressure on smaller operators and margins.